Symposium(9:10 AM - 10:10 AM JST)
[D2-A1]
Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessment
Chairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)
You can change the display size of the timetable.